Bharat Biotech unveils world’s first intranasal COVID-19 vaccine ‘iNCOVACC’
iNCOVACC is a cost-effective vaccine that utilizes a vector-based platform, which can be easily updated with emerging variants leading to large-scale production.
Fri, 27, Jan 2023
14:05 EST
513
Comments
This is a Premium Article, available exclusively to our subscribers.
Read 500+ such News or articles every month by subscribing today!
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login